Will there be a successful human trial of a vaccine for rheumatoid arthritis by the end of 2028?
Saúde e medicinaOne-Off2a
Manifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoAviso de qualidade dos dadosDados da fonte degradados
Dados de 25 de out. de 2026, 20:50 UTC · política pm-quality-4
Previsão da comunidade atualNão 79.8%
Previsores
3
Tipo de pergunta
binary
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Dados do mercado
Atualizado há 20 horas
Desatualizado22/05/23, 01:52 UTC1/01/29, 04:59 UTC
Tendências
Regras
A team of researchers from the University of Toledo report that they were able to suppress the development of rheumatoid arthritis in rats by administering a vaccine containing the protein 14-3-3 zeta:
- https://www.thebrighterside.news/post/life-changing-vaccine-provides-long-lasting-protection-against-rheumatoid-arthritis
- The researchers have apparently filed for a patent for this concept and intend to pursue approval for early clinical trials in humans.
- Will their findings be reproduced in human trials?
- This will resolve YES if any clinical trial is performed to evaluate the efficacy of a vaccine for rheumatoid arthritis based on 14-3-3ζ before the end date, and the trial results show a statistically significant effect.
- Resolves NO otherwise.
